Category: Include on Menu
-
Honeywell, Lockheed Martin shares edge higher following new defense agreements
Shares of Honeywell (NYSE:HON) rose about 1.3% to nearly $225 in premarket trading on Wednesday, while Lockheed Martin (NYSE:LMT) gained roughly 0.4% to around $613. Honeywell Aerospace announced that it has entered into a supplier framework agreement with the U.S. Department of War, supported by a multi-year $500 million investment aimed at expanding defense manufacturing…
-
Real Messenger signs preliminary agreement to explore tech rollout with U.S. brokerage
Real Messenger Corporation (NASDAQ:RMSG) said it has entered into a non-binding memorandum of understanding (MOU) with a publicly traded U.S. real estate brokerage to explore the potential deployment of its integrated technology platform across the brokerage’s network of agents. Under the preliminary agreement, the two companies will evaluate the use of Real Messenger’s platform across…
-
Quoin advances QRX003 development after positive FDA meeting on Netherton syndrome
Quoin Pharmaceuticals (NASDAQ:QNRX) said it received encouraging regulatory feedback from the U.S. Food and Drug Administration (FDA) following a Type C meeting held on March 25, 2026 regarding the development of QRX003, its investigational treatment for Netherton syndrome, a rare genetic skin disorder. According to the company, the FDA indicated that a single Phase 3…
-
Enlivex shares jump after earnings as treasury gains boost results
Shares of Enlivex Therapeutics Ltd (NASDAQ:ENLV) climbed nearly 16% after the company released its fourth-quarter 2025 results, supported by strong gains tied to its treasury holdings. The stock recently traded around $1.30, bringing its year-to-date return to roughly 56%. The biotechnology company said its financial performance was significantly strengthened by the appreciation of RAIN tokens,…
-
BioAffinity shares rise as CyPath Lung growth boosts optimism
Shares of bioAffinity Technologies Inc. (NASDAQ:BIAF) climbed about 19% as investors reacted to developments surrounding the company’s lung cancer diagnostic platform. The company reported strong momentum for CyPath Lung, its non-invasive lung cancer detection test. Revenue from the product increased 87%, while test volumes rose 99% year over year, reflecting accelerating adoption. Based on current…
-
Tower Semiconductor to gain full control of Japan 300mm facility in restructuring deal
Tower Semiconductor (NASDAQ:TSEM) said it will restructure its operations in Japan in a move that will give the company full ownership of a 300mm fabrication plant, while its partner assumes control of a 200mm facility. The company’s shares have risen sharply in recent days, climbing about 27% over the past week to $180.82, near their…
-
Sturm Ruger shares rise after Beretta proposes tender offer
Shares of Sturm, Ruger & Company (NYSE:RGR) climbed about 5% on Wednesday after Beretta Holding S.A. revealed plans to launch a tender offer for up to 20.05% of the company’s shares at $44.80 per share. Ruger stock had closed Tuesday at $40.74. The Italian firearms manufacturer said the proposal is part of a broader effort…
-
PDD shares swing as fourth-quarter revenue roughly meets forecasts
Shares of PDD Holdings (NASDAQ:PDD) traded erratically on Wednesday after the company reported fourth-quarter revenue that largely aligned with market expectations, while earnings declined compared with the previous year. The Chinese e-commerce group generated revenue of 123.91 billion yuan ($17.96 billion) for the quarter ended December 31, slightly below the 124.4 billion yuan average estimate…
-
Maze Therapeutics shares surge after positive Phase 2 data for MZE829
Maze Therapeutics Inc. (NASDAQ:MAZE) reported a fourth-quarter loss of $0.65 per share on Wednesday, while also announcing encouraging results from a Phase 2 clinical trial of its lead drug candidate MZE829. The company’s shares jumped 22.18% in pre-market trading following the release of the trial update. The clinical-stage biopharmaceutical firm generated no revenue in the…
-
Local Bounti shares slip after wider loss despite revenue growth
Shares of Local Bounti Corporation (NYSE:LOCL) declined more than 2% in after-hours trading on Wednesday after the company reported fourth-quarter results that included solid revenue growth but a larger-than-expected loss. The indoor agriculture company generated fourth-quarter revenue of $12.5 million, representing a 24% increase from $10.1 million in the same period a year earlier. The…